Combination chemotherapy of MCNU and interferon alfa-2a (genetical recombination) for advanced multiple myeloma
Hino, N.; Matsuura, W.; Kawakami, K.; Ono, T.; Matsumoto, T.; Tominaga, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Part 1): 693-696
1990
ISSN/ISBN: 0385-0684
PMID: 2321988
Accession: 039604247
PDF emailed within 1 workday: $29.90
Related References
Imamura, Y.; Takagi, T.; Yawata, Y.; Nishinarita, S.; Kosaka, M.; Mikuni, C.; Takatsuki, K.; Sezaki, T.; Mori, M.; Tsuchiya, J. 1994: Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group International Journal of Hematology 59(2): 113-123Adam, Z.; Krejcí, M.; Bacovský, J.; Hejlová, N.; Kuca, B.; Svojgrová, M.; Franková, H.; Gumulec, J.; Janca, J.; Veprek, K.; Januska, B.; Lehanka, F.; Rezek, Z.; Praskac, P.; Cahová, S.; Vránová, M.; Papajík, T.; Králová, E.; Novotná, J.; Scudla, V.; Koza, V.; Drbal, J.; Faber, E.; Mareschová, I.; Hájek, R. 1998: Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group Vnitrni Lekarstvi 44(7): 400-408
Salmon, S.E.; Crowley, J.J.; Grogan, T.M.; Finley, P.; Pugh, R.P.; Barlogie, B. 1994: Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(11): 2405-2414
Takagi, T.; Sakai, C.; Goto, S. 1996: MCNU-VMP therapy A new nitrosourea-based combination chemotherapy for multiple myeloma British Journal of Haematology 93(Suppl 2): 302
Kamiya, O.; Hoshino, A.; Ohara, K.; Nagata, K.; Ono, Y.; Saito, M.; Itou, T.; Yamamoto, K. 1989: Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Part 1): 863-865
Vela Ojeda, J.; Garcia Ruiz Esparza, M.A.; Vazquez, V.; Sanchez Cortes, E.; Tripp Villanueva, F.; Gonzalez Llaven, J. 1994: Chemotherapy and interferon alfa-2b in newly diagnosed patients with multiple myeloma Blood 84(10 Suppl 1): 659A
Buzaid, A.C.; Legha, S.S. 1994: Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma Seminars in Oncology 21(6 Suppl 14: 23-28
Legha, S.S.; Buzaid, A.C. 1993: Role of recombinant interleukin-2 in combination with interferon-alfa and chemotherapy in the treatment of advanced melanoma Semin. Oncol 20(6): 27-32
Legha, S.S.; Buzaid, A.C. 1993: Role of recombinant interleukin-2 in combination with interferon-alfa and chemotherapy in the treatment of advanced melanoma Seminars in Oncology 20(6 Suppl 9: 27-32
Aviles, A.; Alatriste, S.; Diaz Maqueo, J.C.; Nambo, M.J.; Talavera, A.; Garcia, E.L. 1993: Intensive alternating chemotherapy plus interferon alfa 2b increase survival in patients with high-risk multiple myeloma Blood 82(10 Suppl 1): 558A
Mandelli, F.; Avvisati, G.; Amadori, S.; Boccadoro, M.; Gernone, A.; Lauta, V.M.; Marmont, F.; Petrucci, M.T.; Tribalto, M.; Vegna, M.L. 1990: Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy New England Journal of Medicine 322(20): 1430-1434
Dediego, J.; Lopez Hernandez, M.A.; Trueba, E.; Carrillo, T.; Gonzalez Avante, M.; Borbolla, J.R.; Anaya, I.; Alvarado, M.; Jimenez, R.M. 2002: Alfa Interferon as Maintenance Treatment after Poly-Chemotherapy in Multiple Myeloma Preliminary Report of a Randomized Trial Blood 100(11): Abstract No. 5107
Grosbois, B.; Mary, J.Y.; Michaux, J.L.; Facon, T.; Euller Ziegler, L.; Laporte, J.P.; Wetterwald, M.; Monconduit, M. 1994: Continuous or sequential melphalan in combination with interferon Alfa-2A and prednisone in patients with multiple myeloma Preliminary results British Journal of Haematology 87(Suppl 1): 218
Umeda, M.; Shirai, T.; Tsukahara, T.; Kaneko, H.; Yamauchi, M.; Arai, N.; Kosuge, T.; Kato, M.; Shikoshi, K.; Anno, S. 1991: Clinical trial of alpha-interferon (human lymphoblastoid interferon) in combination with VCAP chemotherapy in multiple myeloma Japanese Journal of Clinical Hematology 32(6): 669-674
Gordon, K.B.; Roenigk, H.H.; Gendleman, M. 1997: Treatment of multiple lesions of Bowen disease with isotretinoin and interferon alfa. Efficacy of combination chemotherapy Archives of Dermatology 133(6): 691-693
Gordon, K.B.; Roenigk, H.H.; Gendleman, M. 1997: Treatment of multiple lesions of Bowen disease with isotretinoin and interferon alfa : Efficacy of combination chemotherapy Archives of Dermatology (1960) 133(6): 691-693
Mareschová, I. 1997: High-dose therapy of multiple myeloma with autologous hematopoietic stem cell transplantation and subsequent maintenance therapy with interferon alfa versus interferon alfa and dexamethasone--a randomized clinical study "4W" Vnitrni Lekarstvi 43(5): 345
Coleman, E.A.; Coon, S.K.; Kennedy, R.L.; Lockhart, K.D.; Stewart, C.B.; Anaissie, E.J.; Barlogie, B. 2008: Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma Oncology Nursing Forum 35(3): E53-E61
Coleman, E.A.; Coon, S.K.; Kennedy, R.L.; Lockhart, K.D.; Stewart, C.B.; Anaissie, E.J.; Barlogie, B. 2008: Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma Oncology Nursing Forum 35(3): E53-E61
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273